fullerene c60 has been researched along with rimantadine in 1 studies
| Studies (fullerene c60) | Trials (fullerene c60) | Recent Studies (post-2010) (fullerene c60) | Studies (rimantadine) | Trials (rimantadine) | Recent Studies (post-2010) (rimantadine) |
|---|---|---|---|---|---|
| 3,806 | 5 | 2,170 | 651 | 47 | 138 |
| Protein | Taxonomy | fullerene c60 (IC50) | rimantadine (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 2 | Homo sapiens (human) | 4.4 | |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 7.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, L; Geng, C; Gong, M; Ji, H; Jiang, W; Wang, Z; Xiao, H; Yang, Z | 1 |
1 other study(ies) available for fullerene c60 and rimantadine
| Article | Year |
|---|---|
Antiviral activity of nano carbon fullerene lipidosome against influenza virus in vitro.
Topics: Animals; Antiviral Agents; Carbon; Cell Line; Dogs; Dose-Response Relationship, Drug; Drug Delivery Systems; Fullerenes; Gentian Violet; In Vitro Techniques; Influenza A Virus, H1N1 Subtype; Liposomes; Nanotubes, Carbon; Orthomyxoviridae Infections; Rimantadine | 2008 |